G1 Therapeutics Inc. (GTHX)
NASDAQ: GTHX
· Real-Time Price · USD
7.16
0.01 (0.14%)
At close: Sep 17, 2024, 9:56 PM
G1 Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 58.2M | 84.04M | 82.51M | 77.89M | 89.16M | 57.34M | 51.3M | 46.85M | 28.13M | 24.16M | 31.48M | 42.23M | 63.97M | 59.5M |
Cost of Revenue | 6.14M | 6.82M | 7.2M | 6.93M | 4.97M | 4.54M | 3.75M | 3.13M | 2.61M | 2.44M | 2.02M | 1.64M | 1.05M | 243K |
Gross Profit | 52.05M | 77.23M | 75.32M | 70.96M | 84.2M | 52.81M | 47.55M | 43.72M | 25.52M | 21.72M | 29.46M | 40.58M | 62.92M | 59.26M |
Operating Income | -37.88M | -22.83M | -39.53M | -61.48M | -66.67M | -115.14M | -136.18M | -142.88M | -162.47M | -163.7M | -142.46M | -128.96M | -97.56M | -90.19M |
Interest Income | 1.62M | 2.04M | 2.47M | 2.42M | 2.05M | 1.46M | 748K | 278K | 74K | 33K | 43K | 65K | 108K | 190K |
Pretax Income | -42.96M | -27.48M | -44.85M | -68.04M | -74.8M | -124.26M | -145.86M | -152.47M | -170.56M | -170.31M | -147.43M | -132.52M | -101.12M | -93.13M |
Net Income | -44.77M | -30.59M | -52.91M | -75.68M | -82.74M | -133.38M | -152.45M | -158.82M | -176.02M | -173.51M | -148.35M | -133.68M | -102.89M | -94.67M |
Selling & General & Admin | 60.68M | 64.51M | 71.13M | 79.52M | 87.17M | 95.46M | 100.42M | 100.08M | 99.91M | 99.43M | 95.69M | 96.73M | 90.88M | 80.07M |
Research & Development | 29.25M | 35.55M | 43.71M | 52.92M | 63.69M | 72.49M | 83.32M | 86.52M | 88.08M | 85.99M | 76.22M | 72.81M | 69.6M | 69.38M |
Other Expenses | 3.08M | 3.08M | 3.08M | 3.31M | 285K | 158K | 3K | -372K | -496K | -461K | -346K | -262K | -477K | -599K |
Operating Expenses | 93.01M | 103.13M | 117.92M | 135.52M | 150.86M | 167.95M | 183.73M | 186.59M | 187.99M | 185.42M | 171.92M | 169.54M | 160.48M | 149.45M |
Interest Expense | 8.94M | 8.93M | 10.04M | 10.91M | 11.56M | 11.26M | 10.43M | 9.49M | 7.66M | 6.18M | 4.67M | 3.37M | 3.19M | 2.53M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.05M | -1.05M | -1.05M | -1.05M | n/a | n/a | n/a |
Cost & Expenses | 96.08M | 106.87M | 122.04M | 139.37M | 155.83M | 172.49M | 187.48M | 189.72M | 190.6M | 187.86M | 173.93M | 171.19M | 161.53M | 149.69M |
Income Tax Expense | 1.88M | 3.19M | 8.05M | 7.63M | 7.95M | 9.12M | 6.59M | 6.36M | 5.46M | 3.2M | 925K | 1.16M | 1.77M | 1.6M |
Shares Outstanding (Basic) | 52.48M | 52.17M | 51.84M | 51.78M | 51.67M | 51.65M | 46.28M | 42.8M | 42.71M | 42.69M | 42.41M | 42.38M | 42.12M | 40.7M |
Shares Outstanding (Diluted) | 52.48M | 52.17M | 51.84M | 51.78M | 61.04M | 51.65M | 46.28M | 42.8M | 42.71M | 42.69M | 42.54M | 42.38M | 42.12M | 40.7M |
EPS (Basic) | -0.86 | -0.59 | -1.02 | -1.54 | -1.78 | -2.93 | -3.51 | -3.72 | -4.13 | -4.09 | -3.53 | -3.26 | -2.57 | -2.46 |
EPS (Diluted) | -0.86 | -0.62 | -1.05 | -1.57 | -1.81 | -2.93 | -3.51 | -3.72 | -4.13 | -4.09 | -3.53 | -3.26 | -2.57 | -2.46 |
EBITDA | -35.41M | -19.93M | -35.38M | -56.61M | -62.7M | -112.46M | -134.9M | -142.33M | -162.28M | -163.54M | -142.16M | -128.66M | -97.4M | -90.03M |
EBIT | -34.02M | -18.55M | -34.81M | -57.13M | -63.24M | -113.01M | -135.43M | -142.97M | -162.9M | -164.13M | -142.76M | -129.16M | -97.93M | -90.6M |
Depreciation & Amortization | 492K | 501K | 513K | 526K | 538K | 547K | 530K | 507K | 485K | 464K | 469K | 475K | 503K | 543K |